Phagocytic function and metabolite production in thioacetamide-induced liver cirrhosis: A comparative study in perfused livers and cultured Kupffer cells

Journal of Hepatology

Volumn 24, Issue 4, 1996, Pages 468-477

  Petermann, Henning ^b   Heymann, Steffen ^b   Vogl, Siegfried ^b   Dargel, Rolf ^a  

^a Institute of Pathobiochemistry   (Germany)

^b NONE

Author keywords

Hepatic glucose release; Kupffer cell culture; Liver cirrhosis; Liver perfusion; Macrophages; Phagocytosis

Indexed keywords

GLUCOSE; LACTIC ACID; PYRUVIC ACID; THIOACETAMIDE;

ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; KUPFFER CELL; LIVER CIRRHOSIS; LIVER METABOLISM; LIVER PERFUSION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT;

EID: 0030007151     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80168-1     Document Type: Article

References (39)

1. Toth CA, Thomas P. Liver endocytosis and Kupffer cells. Hepatology 1992; 16: 255-66.
2. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 1990; 192: 245-61.
3. Winwood PJ, Arthur MJP. Kupffer cells: their activation and role in animal models of liver injury and human liver disease. Semin Liver Dis 1993; 13: 50-9.
4. Cooksley WG, Powell LW, Halliday JW. Reticuloendothelial phagocytic function in human liver disease and its relationship to haemolysis. Br J Haematol 1973; 25: 147-64.
5. Hassner A, Kletter Y, Shlag D, Yedvab M, Aronson M, Shibolet S. Impaired monocyte function in liver cirrhosis. Br Med J 1981; 282: 1262-3.
6. Holdstock G, Leslie B, Hill S, Tanner A, Wright R. Monocyte function in cirrhosis. J Clin Pathol 1982; 35: 972-9.
7. Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 1984; 4: 53-8.
8. Abril ER, Jolley CS, Krasourch MA. Divergent effects of chronic ethanol ingestion on Kupffer cell function: implications for alcoholic liver disease. Hepatology 1991; 14: 139A.
9. Noda T, Mimura H, Orita K. Assessment of Kupffer cell function in rats with chronic liver injury caused by CCl4. Hepatogastroenterology 1990; 37: 319-23.
10. Mayanski DN, Schwartz YSH, Kutina SN, Zubakhin AA, Mayanskaya NN, Tsyrendorjiev DD. Mononuclear phagocyte system responsiveness in CCl4-induced liver cirrhosis. Int J Pathol 1993; 74: 229-36.
11. Shiratori Y, Jin'nai H, Teraoka H, Matano S, Matsumoto K, Kamii K, Tanaka M, Okano K. Phagocytic properties of hepatic endothelial cells and splenic macrophages compensating for a decreased phagocytic function of Kupffer cells in chronically ethanol-fed rats. Exp Cell Biol 1989; 57: 300-9.
12. Shiratori Y, Teraoka H, Matano S, Matsumoto K, Kamii K, Tanaka M. Kupffer cell function in chronic ethanol-fed rats. Liver 1989; 9: 351-9.
13. Karakucuk I, Dilly SA, Maxwell JD. Portal tract macrophages are increased in alcoholic liver disease. Histopathology 1989; 14: 245-53.
14. Cowper KB, Currin RT, Dawson TL, Lindert KA, Lemasters JJ, Thurman RG. A new method to monitor Kupffer-cell function continuously in the perfused rat liver. Biochem J 1990; 266: 141-7.
15. 2+ mobilization in the perfused rat liver. Eur J Biochem 1987; 165: 455-60.
16. Kuiper J, Casteleijn E, van Berkel TJ. Regulation of liver metabolism by intercellular communication. Adv Enzyme Regul 1988; 27: 193-208.
17. Kuiper J, de Rijke YB, Zijlstra FJ, van Waas MP, van Berkel TJC. The induction of glycogenolysis in the perfused liver by platelet activating factor is mediated by prostaglandin D2 from Kupffer cells. Biochem Biophys Res Commun 1988; 157: 1288-95.
18. Wiedermann CJ, Niedermühlbichler M, Braunsteiner H. Priming of polymorphonuclear neutrophils by atrial natriuretic peptide in vitro. J Clin Invest 1992; 89: 1580-6.
19. Hummel L, Zimmermann T. Viability criteria of the perfused cirrhotic rat liver. Z Med Labdiagn 1983; 24: 66-70.
20. Zimmermann T, Müller A, Machnik G, Franke H, Schubert H, Dargel R. Biochemical and morphological studies on production and regression of experimental liver cirrhosis induced by thioacetamide in Uje:Wist rats. Z Versuchstierkd 1987; 30: 165-80.
21. Zimmermann T, Gardemann A, Machnik G, Dargel R, Jungermann K. Metabolic and hemodynamic responses of bivascularly perfused rat liver to nerve stimulation, no-radrenaline, acetylcholine and glucagon in thioacetamide-induced micronodular cirrhosis. Hepatology 1992; 15: 464-70.
22. Eyhorn S, Schlayer HJ, Henninger HP, Dieter P, Hermann R, Woort-Menker M, Becker H, Schaefer HE, Decker K. Rat hepatic sinusoidal endothelial cells in monolayer culture. Biochemical and ultrastructural characteristics. J Hepatol 1988; 6: 23-35.
23. Bergmeyer H. Methods of Enzymatic Analysis. New York: Academic Press, 1974; 1257-62.
24. Steinhelper ME, Fisher RA, Revtyak GE, Hanahan DJ, Olson MS. ß2-adrenergic agonist regulation of immune aggregate- and platelet-activating factor-stimulated hepatic metabolism. J Biol Chem 1989; 264: 10976-81.
25. Chao W, Liu H, Zhou W, Hanahan DJ, Olson MS. Regulation of platelet-activating factor receptor and platelet-activating factor receptor-mediated biological responses by cAMP in rat Kupffer cells. J Biol Chem 1990; 265:17576-83.
26. Mills LR, Scheuer PJ. Hepatic sinusoidal macrophages in alcoholic liver disease. J Pathol 1985; 17: 147-54.
27. Horisawa M, Goldstein G, Waxman A, Reynolds T. The abnormal hepatic scan of chronic liver disease: its relationship to hemodynamics and colloid extraction. Gastroenterology 1976; 71: 210-3.
28. Lough J, Rosenthall L, Arzoumanian A, Goresky CA. Kupffer cell depletion associated with capillarization of liver sinusoids in carbontetrachloride-induced rat liver cirrhosis. J Hepatol 1987; 5: 190-8.
29. Triarhou L, Cerro M. Colloidal carbon as a multilevel marker for experimental lesions. Experientia 1985; 41: 620-1.
30. D'Souza NB, Bagby GJ, Lang CH, Deaciuc IV, Spitzer JJ. Ethanol alters the metabolic response of isolated perfused rat liver to a phagocytic stimulus. Alcohol Clin Exp Res 1993; 17: 147-54.
31. Reichen J, Le M. Verapamil favorably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver. J Clin Invest 1986; 78: 448-55.
32. Law SKA. Complement receptors. In: Horton MA, ed. Macrophages and Related Cells. New York: Plenum Press, 1993; 223-59
33. Myones BL, Dalzell JG, Hogg N, Ross GD. Neutrophil and monocyte cell surface p150,95 Has i3Cb-receptor (CR4) activity resembling CR3. J Clin Invest 1988; 82: 640-51.
34. Benoit JN, Granger DN. Splanchnic hemodynamics in chronic portal hypertension. Semin Liver Dis 1986; 6: 287-98.
35. Henrikson JH, Staun-Olsen P, Borg-Mogensen N, Fahrenkrug J. Circulating endogenous vasoactive intestinal polypeptide (VIP) in patients with uraemia and liver cirrhosis. Eur J Clin Invest 1986; 16: 211-6.
36. Huet M-P, Pomier-Layrargues G, Villeneuve J-P, Varin F, Viallett A. Intrahepatic circulation in liver disease. Semin Liver Dis 1986; 6: 277-86.
37. Kimura K, Shiota M, Mochizuki K, Ohta M, Sugano T. Different preparations of zymosan induce glycogenolysis independently in the perfused rat liver. Biochem J 1992; 283: 773-9.
38. Hermsdorf T, Dettmer D, Hofmann E. Differences in the accessibility of the ß-adrenergic receptor in isolated hepatocytes from foetal and adult rats. Cell Signal 1991; 3: 299-303.
39. Tosh D, Agius L. Glycogen degradation by adrenergic agonists and glucagon in periportal and perivenous rat hepatocyte cultures. Biochim Biophys Acta 1994; 1221: 238-42.